Dare Bioscience Inc expected to post a loss of 10 cents a share - Earnings Preview

Dare Bioscience

04/08/2023 19:38

* Dare Bioscience Inc  DARE.OQ   DARE.O  is expected to show
a
fall in quarterly revenue when it reports  results on August
10. 
    * The San Diego California-based  company is expected to
report  a
92.7% decrease in revenue to $733.33 thousand from $10 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Dare Bioscience Inc
is
for a loss of 10 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Dare
Bioscience
Inc is $5.5​, above​ its last closing price of $0.73. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.10       -0.10      -0.09     Beat    10
 Dec. 31 2023  -0.14       -0.14      -0.19     Missed  -39
 Sep. 30 2022  -0.11       -0.12      -0.08     Beat    31.9​
 Jun. 30 2022  -0.06       -0.06      0.00      Beat    100
 ​​Mar.        -0.14       -0.14      -0.10     Beat    29.8
 31 2022                                                
 Dec. 31 2021  -0.20       -0.15      -0.18     Missed  -23.3​
 Sep. 30 2021  -0.08       -0.13      -0.18     Missed  -35.8
 Jun. 30 2021  -0.16       -0.16      -0.18     Missed  -14.3
 This summary was machine generated August 4 at 18:37 GMT.  All
figures in US dollars  unless otherwise stated